Búsqueda | Portal de Búsqueda de la BVS

1.

Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.

Kaito, Yuta; Sugimoto, Emi; Nakamura, Fumi; Tsukune, Yutaka; Sasaki, Makoto; Yui, Shunsuke; Yamaguchi, Hiroki; Goyama, Susumu; Nannya, Yasuhito; Mitani, Kinuko; Tamura, Hideto; Imai, Yoichi.

Haematologica ; 109(4): 1107-1120, 2024 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-37731380

2.

RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.

Masuda, Tatsuya; Maeda, Shintaro; Shimada, Sae; Sakuramoto, Naoya; Morita, Ken; Koyama, Asami; Suzuki, Kensho; Mitsuda, Yoshihide; Matsuo, Hidemasa; Kubota, Hirohito; Kato, Itaru; Tanaka, Kuniaki; Takita, Junko; Hirata, Masahiro; Kataoka, Tatsuki R; Nakahata, Tatsutoshi; Adachi, Souichi; Hirai, Hideyo; Mizuta, Shuichi; Naka, Kazuhito; Imai, Yoichi; Kimura, Shinya; Sugiyama, Hiroshi; Kamikubo, Yasuhiko.

Cancer Sci ; 113(2): 529-539, 2022 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-34902205

3.

[Mechanism of action and clinical results of immunotherapy for multiple myeloma].

Imai, Yoichi.

Rinsho Ketsueki ; 63(9): 1180-1187, 2022.

Artículo en Japonés | MEDLINE | ID: mdl-36198543

4.

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.

Yasui, Hiroshi; Kobayashi, Masayuki; Sato, Kota; Kondoh, Kanya; Ishida, Tadao; Kaito, Yuta; Tamura, Hideto; Handa, Hiroshi; Tsukune, Yutaka; Sasaki, Makoto; Komatsu, Norio; Tanaka, Norina; Tanaka, Junji; Kizaki, Masahiro; Kawamata, Toyotaka; Makiyama, Junya; Yokoyama, Kazuaki; Imoto, Seiya; Tojo, Arinobu; Imai, Yoichi.

Int J Clin Oncol ; 26(11): 2142-2150, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34259983

5.

[Current status and future prospects of immunotherapy for multiple myeloma].

Imai, Yoichi.

Rinsho Ketsueki ; 62(5): 407-417, 2021.

Artículo en Japonés | MEDLINE | ID: mdl-34108322

6.

[Cooccurrence of classic Hodgkin lymphoma and multiple myeloma].

Andoh, Shohei; Yokoyama, Kazuaki; Uchida, Sanshiro; Makiyama, Junya; Kawamata, Toyotaka; Yasui, Hiroshi; Ota, Yasunori; Imai, Yoichi; Tojo, Arinobu.

Rinsho Ketsueki ; 62(1): 14-19, 2021.

Artículo en Japonés | MEDLINE | ID: mdl-33551419

7.

UGGT1 retains proinsulin in the endoplasmic reticulum in an arginine dependent manner.

Cho, Jaeyong; Hiramoto, Masaki; Masaike, Yuka; Sakamoto, Satoshi; Imai, Yoichi; Imai, Yumi; Handa, Hiroshi; Imai, Takeshi.

Biochem Biophys Res Commun ; 527(3): 668-675, 2020 06 30.

Artículo en Inglés | MEDLINE | ID: mdl-32423812

8.

Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.

Tanaka, Norina; Imai, Yoichi; Yoshinaga, Kentaro; Shiseki, Masayuki; Tanaka, Junji.

Ann Hematol ; 99(11): 2587, 2020 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-32980889

9.

Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.

Tanaka, Norina; Imai, Yoichi; Yoshinaga, Kentaro; Shiseki, Masayuki; Tanaka, Junji.

Ann Hematol ; 99(11): 2577-2586, 2020 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-32945942

10.

High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases.

Hirano, Mitsuhito; Kimura, Koichi; Ishigaki, Tomohiro; Nojima, Masanori; Daimon, Masao; Morita, Hiroyuki; Takenaka, Katsu; Xu, Boqing; Sawada, Naoko; Hirokawa, Megumi; Komuro, Issei; Morisaki, Takayuki; Yotsuyanagi, Hiroshi; Kawamata, Toyotaka; Yokoyama, Kazuaki; Konuma, Takaaki; Kato, Seiko; Yasui, Hiroshi; Nagamura-Inoue, Tokiko; Uchimaru, Kaoru; Takahashi, Satoshi; Imai, Yoichi; Tojo, Arinobu.

Circ J ; 84(11): 1957-1964, 2020 10 23.

Artículo en Inglés | MEDLINE | ID: mdl-33041289

11.

Hypersensitivity reaction to ß-lactam antibiotics in patients with adult T-cell leukemia/lymphoma treated with mogamulizumabâ©.

Yasu, Takeo; Imai, Yoichi; Ohno, Nobuhiro; Uchimaru, Kaoru; Kurokawa, Yosuke; Tojo, Arinobu.

Int J Clin Pharmacol Ther ; 55(10): 807-810, 2017 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-28793956

12.

[Autologous peripheral blood stem cell transplantation for double-refractory myeloma with K-RAS and N-RAS mutations].

Jimbo, Koji; Yokoyama, Kazuaki; Ogawa, Miho; Hirano, Mitsuhito; Ochi, Kiyosumi; Kobayashi, Masayuki; Yusa, Nozomi; Shimizu, Eigo; Kawamata, Toyotaka; Yasui, Hiroshi; Ohno, Nobuhiro; Yamaguchi, Rui; Imoto, Seiya; Furukawa, Yoichi; Miyano, Satoru; Imai, Yoichi; Tojo, Arinobu.

Rinsho Ketsueki ; 58(12): 2380-2385, 2017.

Artículo en Japonés | MEDLINE | ID: mdl-29332870

13.

Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies.

Imai, Yoichi; Maru, Yoshiro; Tanaka, Junji.

Cancer Sci ; 107(11): 1543-1549, 2016 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-27554046

14.

Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.

Tsukune, Yutaka; Sasaki, Makoto; Odajima, Takeshi; Isoda, Atsushi; Matsumoto, Morio; Koike, Michiaki; Tamura, Hideto; Moriya, Keiichi; Ito, Shigeki; Asahi, Maki; Imai, Yoichi; Tanaka, Junji; Handa, Hiroshi; Koiso, Hiromi; Tanosaki, Sakae; Hua, Jian; Hagihara, Masao; Yahata, Yuriko; Suzuki, Satoko; Watanabe, Sumio; Sugimori, Hiroki; Komatsu, Norio.

Ann Hematol ; 95(9): 1465-72, 2016 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-27358178

15.

Intracellular reactive oxygen species mark and influence the megakaryocyte-erythrocyte progenitor fate of common myeloid progenitors.

Shinohara, Akihito; Imai, Yoichi; Nakagawa, Masahiro; Takahashi, Tsuyoshi; Ichikawa, Motoshi; Kurokawa, Mineo.

Stem Cells ; 32(2): 548-57, 2014 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-24167091

16.

[AML treatment strategy based on cytogenetic abnormalities and somatic mutations].

Imai, Yoichi.

Rinsho Ketsueki ; 56(10): 1932-41, 2015 Oct.

Artículo en Japonés | MEDLINE | ID: mdl-26458431

17.

[Discovered roles of MLL in pathogenesis of multiple myeloma].

Imai, Yoichi; Ohta, Eri.

Nihon Rinsho ; 72(6): 1047-51, 2014 Jun.

Artículo en Japonés | MEDLINE | ID: mdl-25016802

18.

Novel treatment strategies for hematological malignancies in the immunotherapy era.

Imai, Yoichi.

Int J Hematol ; 2024 Jun 11.

Artículo en Inglés | MEDLINE | ID: mdl-38861242

19.

Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.

Kaito, Yuta; Imai, Yoichi.

Int J Hematol ; 2024 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-38693419

20.

Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.

Ogawa, Miho; Yokoyama, Kazuaki; Hirano, Mitsuhito; Jimbo, Koji; Ochi, Kiyosumi; Kawamata, Toyotaka; Ohno, Nobuhiro; Shimizu, Eigo; Yokoyama, Nozomi; Yamaguchi, Rui; Imoto, Seiya; Uchimaru, Kaoru; Takahashi, Naoto; Miyano, Satoru; Imai, Yoichi; Tojo, Arinobu.

Br J Haematol ; 183(5): 842-845, 2018 12.

Artículo en Inglés | MEDLINE | ID: mdl-29265350

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.

RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.

[Mechanism of action and clinical results of immunotherapy for multiple myeloma].

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.

[Current status and future prospects of immunotherapy for multiple myeloma].

[Cooccurrence of classic Hodgkin lymphoma and multiple myeloma].

UGGT1 retains proinsulin in the endoplasmic reticulum in an arginine dependent manner.

Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.

Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.

High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases.

Hypersensitivity reaction to ß-lactam antibiotics in patients with adult T-cell leukemia/lymphoma treated with mogamulizumabâ©.

[Autologous peripheral blood stem cell transplantation for double-refractory myeloma with K-RAS and N-RAS mutations].

Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies.

Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.

Intracellular reactive oxygen species mark and influence the megakaryocyte-erythrocyte progenitor fate of common myeloid progenitors.

[AML treatment strategy based on cytogenetic abnormalities and somatic mutations].

[Discovered roles of MLL in pathogenesis of multiple myeloma].

Novel treatment strategies for hematological malignancies in the immunotherapy era.

Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.

Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.